Join the DDA or

Read the MHRA January drug safety update

Palexia seizure risk identified

January 15th 2019

Tagged: Clinical guidance news

By Ailsa Colquhoun

The MHRA has published its January drug safety update.

This includes the following articles:

  • Tapentadol (Palexia): risk of seizures and reports of serotonin syndrome when co-administered with other medicines
  • Ipilimumab (Yervoy): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation
  • Yellow Card App: download the updated App to receive the latest MHRA safety news and report suspected side effects, including in pregnancy

For all the latest news of the 2019 DDA annual conference...

Learn more